Cite
HARVARD Citation
Sriranjan, R. et al. (2022). Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. BMJ open. 12 (10), p. . [Online].